Caractérisation de modèles murins de la maladie de Parkinson (MPTP, PITX3) et modification des cellules souches hématopoïétiques pour stimuler la production du " Brain-derived neurotrophic factor " (BDNF)

Authors: Laplante-Campbell, Marie-Pier
Advisor: Rivest, Serge
Abstract: Parkinson’s disease is a common neurodegenerative disorder characterized by locomotor dysfunctions. These motor symptoms are due to a severe loss of dopaminergic neurons in the substantia nigra pars compacta. Parkinson’s patients also have a deficit in the expression of the brain-derived neurotrophic factor (BDNF). This neurotrophin plays an important role in the development, survival and neurotransmission of dopaminergic neurons. Considering that hematopoietic stem cells can infiltrate damaged brain regions, we have modified these cells to deliver the neurotrophic factor in Parkinson’s disease mouse models. We have demonstrated that modification of bone marrow cells attenuates the locomotor dysfonctions in Parkinson’s mice. In addition, overproduction of BDNF by hematopoietic cells increases BDNF levels in the substantia nigra, cortex and thalamus. Overproduction of BDNF also stimulates biosynthesis of dopamine in the substantia nigra.
Document Type: Mémoire de maîtrise
Issue Date: 2008
Open Access Date: 13 April 2018
Permalink: http://hdl.handle.net/20.500.11794/20555
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
SizeFormat 
25874.pdf4.93 MBAdobe PDFView/Open
All documents in CorpusUL are protected by Copyright Act of Canada.